% IMPORTANT: The following is UTF-8 encoded. This means that in the presence % of non-ASCII characters, it will not work with BibTeX 0.99 or older. % Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or % “biber”. @ARTICLE{Elmenhorst:134640, author = {Elmenhorst, David and Kroll, Tina and Wedekind, Franziska and Weißhaupt, Angela and Beer, Simone and Bauer, Andreas}, title = {{I}n {V}ivo {K}inetic and {S}teady-{S}tate {Q}uantification of 18{F}-{CPFPX} {B}inding to {R}at {C}erebral {A}1 {A}denosine {R}eceptors: {V}alidation by {D}isplacement and {A}utoradiographic {E}xperiments}, journal = {Journal of nuclear medicine}, volume = {54}, number = {8}, issn = {0161-5505}, address = {Reston, Va.}, publisher = {SNM84042}, reportid = {FZJ-2013-02757}, pages = {1411-1419}, year = {2013}, abstract = {In vivo imaging of the A1 adenosine receptor (A1AR) using (18)F-8-cyclopentyl-3-(3-fluoropropyl)-1-propylxanthine ((18)F-CPFPX) and PET has become an important tool for studying physiologic and pathologic states of the human brain. However, dedicated experimental settings for small-animal studies are still lacking. The aim of the present study was therefore to develop and evaluate suitable pharmacokinetic models for the quantification of the cerebral A1AR in high-resolution PET. METHODS: On a dedicated animal PET scanner, 15 rats underwent (18)F-CPFPX PET scans of 120-min duration. In all animals, arterial blood samples were drawn and corrected for metabolites. The radioligand was injected either as a bolus or as a bolus plus constant infusion. For the definition of unspecific binding, the A1AR selective antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) was applied. After PET, the brains of 9 animals were dissected and in vitro saturation binding was performed using high-resolution (3)H-DPCPX autoradiography. RESULTS: The kinetics of (18)F-CPFPX were well described by either compartmental or noncompartmental models based on arterial input function. The resulting distribution volume ratio correlated with a low bias toward identity with the binding potential derived from a reference region (olfactory bulb) approach. Furthermore, PET quantification correlated significantly with autoradiographic in vitro data. Blockade of the A1AR with DPCPX identified specific binding of about $45\%$ in the reference region olfactory bulb. CONCLUSION: The present study provides evidence that (18)F-CPFPX PET based on a reference tissue approach can be performed quantitatively in rodents in selected applications. Specific binding in the reference region needs careful consideration for quantitative investigations.}, cin = {INM-2 / ZEA-2}, ddc = {610}, cid = {I:(DE-Juel1)INM-2-20090406 / I:(DE-Juel1)ZEA-2-20090406}, pnm = {333 - Pathophysiological Mechanisms of Neurological and Psychiatric Diseases (POF2-333)}, pid = {G:(DE-HGF)POF2-333}, typ = {PUB:(DE-HGF)16}, pubmed = {pmid:23740103}, UT = {WOS:000322692400055}, doi = {10.2967/jnumed.112.115576}, url = {https://juser.fz-juelich.de/record/134640}, }